Get the Full TPD Readout from AACR
From thousands of presentations at AACR 2026, our analysts identified 188 TPD‑relevant abstracts, an 18% increase compared with 2025, and the highest total to date!
We’ve translated this growing volume of data into clear, decision‑ready insight, structuring it so you can quickly understand where activity is concentrating and what’s changing.
The report includes:
- 188 TPD‑relevant abstracts analyzed, including 17 clinical and 171 preclinical studies
- A clear breakdown of TPD activity by therapeutic class, from molecular glues and PROTACs to emerging modalities
- 43 newly disclosed TPD drugs, highlighting sustained innovation across the field
- Concise summaries of every abstract, with direct links for fast, targeted follow‑up
You May Also Be Interested In…
Learn More About TPD
What is Beacon TPD?
- The Most Comprehensive Way to Search the TPD Drug Development Landscape: Unique search ontologies based on TPD drug and trial characteristics
- Market Leading Approach to TPD Preclinical & Clinical Data Curation: Manual curation of key TPD research and development data points by TPD research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search TPD company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
